赛克洛塞林和阳极tDCS的协同效应:系统性审查和元分析
Fernanda Cristina Poscai Ribeiro1, July Samy Brasil2, Diego Carneiro Vianna2
1Department of Internal Medicine, Universidade Do Oeste Paulista, Guarujá, SP, Brazil. fernandaposcai@gmail.com.
Experimental brain research
|March 18, 2025
概括
赛克洛塞林可能会增强跨直流刺激 (tDCS) 对大脑刺激性的影响. 然而,这次系统性审查发现显著临床改善的证据有限,这表明需要进一步研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 超直流刺激 (tDCS) 是一种非侵入性神经调节技术,可以影响皮层刺激性和神经可塑性.
- 环素是一种NMDA受体部分激动剂,可以通过调节受体活性来增强tDCS效应.
研究的目的:
- 系统地审查和元分析环素和阳极tDCS对皮质刺激性和临床结果的协同作用.
- 评估赛克洛塞林增加tDCS诱导的神经可塑性和治疗疗效的潜力.
主要方法:
- 在多个数据库中进行了全面的文献搜索.
- 确定了五项符合条件的研究,并纳入了系统性审查和元分析.
- 提取和分析了皮层刺激性和临床结果的数据.
主要成果:
- 在tDCS后60分钟内,环素显著延长皮层刺激性 (SMD:0.66,95%CI:0.05至1.27).
- 对皮层刺激能力的最明显的影响是在100毫克的环素剂量 (SMD:0.78,95% CI:0.26至1.31) 观察到的.
- 在包括的研究中,抑郁症或运动学习的临床改善并不总是显著的.
结论:
- 赛克洛塞林似乎延长了tDCS诱导的皮质刺激的持续时间.
- 这些发现表明,环素有可能提高tDCS的疗效.
- 需要更严格的临床试验来验证将Cycloserine与tDCS结合的治疗益处.
相关概念视频
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
872
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
872
Electroconvulsive Therapy
21
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21


